Sign Out
Pregnant Women: In pregnant women and women who may be pregnant, administer Fluticasone Furoate Nitto Nasal Spray 27.5 mcg/spray only when the therapeutic benefits outweigh the risks. Glucocorticoids have been shown to be teratogenic in experimental animals, but no teratogenic effects have been observed with inhalation of fluticasone furoate in rats (up to 91 µg/kg/day) or rabbits (up to 8 µg/kg/day), and no effects on development before and after birth have been observed in rats. Low fetal weight, increased incidence of incomplete ossification (in rats), and miscarriages (in rabbits) related to maternal toxicity due to exposure by inhalation at high doses have been reported.
Breast-feeding Women: Consider whether to continue or discontinue breastfeeding with the benefits of treatment and benefits of breastfeeding in mind.
Continue with Google